Sleep Disorders of Patients With Diseases of the Nervous System
Launched by NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE (NINDS) · Nov 3, 1999
Trial Information
Current as of March 18, 2025
Completed
Keywords
ClinConnect Summary
The objective of this protocol is to provide training in a broad range of neurological sleep disorders to clinical associates who are eligible for sitting in the Board examination of the Added Qualification of Clinical Neurophysiology administered by the American Board of Psychiatry and Neurology. This protocol is to supplement small accrual of research patients who are referred from within the NIH.
Gender
ALL
Eligibility criteria
- * IINCLUSION CRITERIA:
- Patients 5 years of age and older, with the following referring diagnoses:
- • Narcolepsy
- • Hypersomnia
- • REM behavior disorder
- • Frontal nocturnal dystonia
- • Restless legs syndrome
- • Insomnia
- • Parasomnia
- • Nocturnal epileptic seizure
- • Nocturnal movement disorder
- • Sleep-related diagnostic dilemma
- • Sleep apnea associated with neurological disorders
- • Patients who are ambulatory and who are able to comply with the study procedures.
- • Patients who are able to understand and sign the informed consent. (Parent or guardian for minors).
- EXCLUSION CRITERIA:
- • Patients who have been diagnosed with acute and progressive neurological disorders.
- • Patients who are unable to comply with the study procedures and require other than standard care.
About National Institute Of Neurological Disorders And Stroke (Ninds)
The National Institute of Neurological Disorders and Stroke (NINDS) is a leading component of the National Institutes of Health (NIH), dedicated to advancing our understanding of the brain and nervous system through innovative research. NINDS sponsors and conducts clinical trials aimed at developing effective treatments and improving patient outcomes for a wide range of neurological disorders, including stroke, epilepsy, multiple sclerosis, and neurodegenerative diseases. By fostering collaboration among researchers, healthcare providers, and patient communities, NINDS plays a pivotal role in transforming scientific discoveries into clinical applications, ultimately enhancing the quality of life for individuals affected by neurological conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bethesda, Maryland, United States
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Related articles
Similar Trials